Cardinal Health announced two acquisitions Monday to expand its home-care business, a segment it has prioritized for faster growth and higher margins.
The deals—AdaptHealth’s diabetes unit and Strive Medical—cost a combined $360 million in cash. The purchases continue a shift of capital from legacy distribution operations into businesses serving patients at home.
Expanding home-care services
The larger deal brings AdaptHealth’s diabetes business into Cardinal Health’s portfolio. The unit serves over 225,000 patients annually, shipping continuous glucose monitors, insulin pumps, and related supplies directly to homes. Strive Medical, the smaller acquisition, focuses on urology, wound care, ostomy, and incontinence products for about 20,000 patients each year.
These moves follow two larger transactions in late 2024. Cardinal Health spent roughly $2.8 billion for a majority stake in GI Alliance, a physician practice management group, and $1.1 billion to acquire Advanced Diabetes Supply Group. The GI Alliance investment marked a push into medical practice administration, while the other reinforced the home-care focus.
Analysts described the latest deals as strategic additions supporting long-term growth. The company’s “other” segment—home solutions, nuclear and precision health, and logistics—reported a 10.5% operating margin in the fiscal third quarter. Pharmaceutical distribution, by comparison, posted 1.4%, and global medical products fell below 1%.
Those figures explain why management allocates capital toward smaller, higher-margin businesses. The shift does not aim to replace distribution, which remains a steady, cash-generating engine. However, distribution operates with limited pricing power. Home care, in contrast, benefits from aging populations and the movement of medical services out of hospitals.
Related: Russia edges toward crypto trade as Bitcoin surges
Small deals, gradual impact
Cardinal Health is not making a dramatic bet on home care. The $360 million price represents a modest investment relative to its size. Instead, the acquisitions serve as incremental steps, each adding hundreds of thousands of patients and modest margin improvements.
Analysts viewed the diabetes expansion as a logical and value-adding move for a platform showing recent growth. The observation aligns with a broader approach: Cardinal Health avoids chasing rapid expansion. It builds a diversified healthcare services company through smaller transactions.
Investors have taken notice. A portfolio director said the company has established a strong acquisition track record, and the latest moves continue that approach.
Results will not appear immediately. Integrating even small businesses takes time. Systems must align, employees require training, and patients need to adapt. The financial impact will emerge gradually in quarterly reports over the next few years rather than in a single earnings surprise.
For now, the approach remains deliberate. The deals announced Monday form small pieces of a larger strategy balancing stability with growth and distribution with direct patient care. Similar shifts in other industries show how specialized products gain traction as consumer preferences evolve.
